MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Abbott Laboratories Company Profile (NYSE:ABT)

Consensus Ratings for Abbott Laboratories (NYSE:ABT) (?)
Ratings Breakdown: 6 Hold Rating(s), 15 Buy Rating(s)
Consensus Rating:Buy (Score: 2.71)
Consensus Price Target: $46.29 (17.75% upside)

Analysts' Ratings History for Abbott Laboratories (NYSE:ABT)
Show:
DateFirmActionRatingPrice TargetActions
6/21/2016Edward JonesUpgradeHold -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/18/2016BarclaysReiterated RatingBuy$48.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/14/2016Jefferies GroupBoost Price TargetBuy$44.00 -> $45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/8/2016Credit SuisseReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/12/2016Wells FargoReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/2/2016BMO Capital MarketsReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/30/2016S&P Equity ResearchReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/30/2016GabelliReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2016BTIG ResearchReiterated RatingBuy$45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2016Piper JaffrayDowngradeOverweight -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/21/2016Cowen and CompanyReiterated RatingNeutral -> Buy$44.00 -> $48.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/14/2016First GlobalDowngradeOutperform -> MarketperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/11/2016RBC CapitalReiterated RatingOutperform$45.00 -> $48.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/28/2016Stifel NicolausBoost Price TargetBuy$42.00 -> $47.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/28/2016Leerink SwannBoost Price TargetMarket Perform$37.00 -> $40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/19/2016Deutsche BankReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/5/2016ArgusUpgradeHold -> Buy$50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/29/2016Raymond JamesLower Price TargetOutperform$46.00 -> $42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/29/2016Goldman SachsLower Price TargetNeutral$44.00 -> $40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/29/2016William BlairDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/5/2016Bank of AmericaReiterated RatingBuy$53.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/4/2016Morgan StanleyDowngradeOverweight -> Equal Weight$50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/27/2015Evercore Partners Inc.Initiated CoverageBuy$54.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/26/2015Evercore ISIInitiated CoverageBuy$54.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/23/2015JPMorgan Chase & Co.Boost Price TargetNeutral$46.00 -> $48.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/1/2014 forward)
Earnings History for Abbott Laboratories (NYSE:ABT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/20/2016ListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/20/2016Q116$0.39$0.41$4.77 billion$4.90 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/28/2016Q415$0.61$0.62$5.31 billion$5.20 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/21/2015Q315$0.53$0.54$5.16 billion$5.15 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/22/2015Q215$0.50$0.52$5.15 billion$5.20 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/22/2015Q115$0.42$0.47$4.85 billion$4.90 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/29/2015Q414$0.69$0.71$5.48 billion$5.36 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/22/2014Q314$0.59$0.62$5.62 billion$5.10 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/16/2014Q214$0.51$0.54$5.53 billion$5.55 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/16/2014Q114$0.36$0.41$5.29 billion$5.24 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/22/2014Q413$0.58$0.58$5.72 billion$5.66 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/16/2013Q313$0.52$0.55$5.46 billion$5.37 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/17/2013Q2 2013$0.44$0.46$5.53 billion$5.45 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/17/2013Q1 2013$0.41$0.42$5.42 billion$5.38 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/23/2013Q4 2012$1.50$1.51$10.58 billion$10.80 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/17/2012$1.28$1.30ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/18/2012$1.22$1.23ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/18/2012$1.00$1.03ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/25/2012$1.44$1.45ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/19/2011$1.17$1.18ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/20/2011$1.12$1.12ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/20/2011$0.90$0.91ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/26/2011$1.29$1.30ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Abbott Laboratories (NYSE:ABT)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163$0.39$0.40$0.39
Q2 20164$0.51$0.54$0.53
Q3 20163$0.59$0.60$0.60
Q4 20163$0.65$0.69$0.67
Q1 20173$0.44$0.51$0.47
Q2 20173$0.57$0.61$0.59
Q3 20172$0.63$0.66$0.65
Q4 20173$0.70$0.75$0.73
Q1 20181$0.51$0.51$0.51
(Data provided by Zacks Investment Research)
Current Dividend Information for Abbott Laboratories (NYSE:ABT)
Annual Dividend:$1.04
Dividend Yield:2.65%
Payout Ratio:47.27%
Dividend Growth:-21.80% (3 Year Average)

Dividend History for Abbott Laboratories (NYSE:ABT)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
6/10/2016quarterly$0.262.75%7/13/20167/15/20168/15/2016Tweet This Announcement  Share This Announcement on StockTwits
2/19/2016quarterly$0.262.66%4/13/20164/15/20165/16/2016Tweet This Announcement  Share This Announcement on StockTwits
12/11/2015quarterly$0.262.32%1/13/20161/15/20162/16/2016Tweet This Announcement  Share This Announcement on StockTwits
9/17/2015quarterly$0.242.22%10/13/201510/15/201511/15/2015Tweet This Announcement  Share This Announcement on StockTwits
6/12/2015quarterly$0.242%7/13/20157/15/20158/15/2015Tweet This Announcement  Share This Announcement on StockTwits
2/20/2015quarterly$0.242.03%4/13/20154/15/20155/15/2015Tweet This Announcement  Share This Announcement on StockTwits
12/12/2014quarterly$0.242.21%1/13/20151/15/20152/13/2015Tweet This Announcement  Share This Announcement on StockTwits
9/11/2014quarterly$0.222.07%10/10/201410/15/201411/15/2014Tweet This Announcement  Share This Announcement on StockTwits
6/13/2014quarterly$0.222.21%7/11/20147/15/20148/15/2014Tweet This Announcement  Share This Announcement on StockTwits
2/21/2014quarterly$0.222.26%4/11/20144/15/20145/15/2014Tweet This Announcement  Share This Announcement on StockTwits
10/16/2013quarterly$0.222.37%1/13/20141/15/20142/15/2014Tweet This Announcement  Share This Announcement on StockTwits
9/12/2013quarterly$0.141.61%10/10/201310/15/201311/15/2013Tweet This Announcement  Share This Announcement on StockTwits
6/14/2013quarterly$0.141.52%7/11/20137/15/20138/15/2013Tweet This Announcement  Share This Announcement on StockTwits
2/15/2013quarterly$0.141.61%4/11/20134/15/20135/15/2013Tweet This Announcement  Share This Announcement on StockTwits
12/14/2012quarterly$0.140.86%1/11/20131/15/20132/15/2013Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)
Insider Trading History for Abbott Laboratories (NYSE:ABT)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/28/2016Hubert L AllenEVPSell3,400$37.14$126,276.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/15/2016Jared WatkinSVPSell552$37.63$20,771.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/1/2016Brian B YoorCFOSell565$39.49$22,311.85View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/28/2016Deepak S NathSVPSell53$41.31$2,189.43View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/31/2016Jaime ContrerasSVPSell462$41.78$19,302.36View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/29/2016Brian B YoorCFOSell865$39.12$33,838.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/29/2016Deepak S NathSVPSell793$39.27$31,141.11View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/29/2016Robert B FordEVPSell1,706$39.28$67,011.68View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/29/2016Robert E FunckVPSell1,333$39.30$52,386.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/22/2016Jared WatkinSVPSell554$39.09$21,655.86View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/16/2016Deepak S. NathSVPSell171$37.13$6,349.23View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/16/2015Miles D. WhiteCEOSell438,000$46.00$20,148,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/18/2015Stephen R. FussellEVPSell13,096$50.46$660,824.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/27/2015Heather L MasonEVPSell13,500$47.45$640,575.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/27/2015Roger BirdSVPSell28,548$47.57$1,358,028.36View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/26/2015J. Scott WhiteSVPSell12,483$46.68$582,706.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2015Jaime ContrerasSVPSell9,209$47.34$435,954.06View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2015John M CapekEVPSell34,292$45.66$1,565,772.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/25/2014Jaime ContrerasSVPSell51,600$44.07$2,274,012.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/29/2014Miles D WhiteCEOSell440,800$42.52$18,742,816.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/3/2014John LandgrafEVPSell17,293$39.38$680,998.34View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/3/2014Katherine DoyleSVPSell6,639$39.01$258,987.39View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/3/2014Robert FunckVPSell1,413$38.97$55,064.61View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/18/2014John LandgrafEVPSell1,583$39.10$61,895.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/29/2014Michael WarmuthEVPSell11,430$36.21$413,880.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/6/2013Jean-Yves PaveeSVPSell5,855$37.46$219,328.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/7/2013Stephen FussellEVPSell10,466$37.59$393,416.94View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/30/2013Jaime ContrerasSVPSell25,368$36.85$934,810.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/7/2013Heather L MasonSVPSell12,000$37.01$444,120.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/1/2013William A OsbornDirectorBuy10,000$33.86$338,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Abbott Laboratories (NYSE:ABT)
DateHeadline
07/01/16 10:11 AMAnalyst Rating Trends to Observe: Abbott Laboratories (NYSE:ABT) , Opko Health Inc (NASDAQ:OPK) - Street Updates
06/30/16 02:15 PMSpotlight on Active Stock: Abbott Laboratories (NYSE:ABT) - Telanagana Press
06/30/16 10:07 AMHot Stocks Alert - Abbott Laboratories, (NYSE:ABT), Hecla Mining Company, (NYSE:HL) - Hot Stocks Point
06/30/16 10:07 AMAbbott Laboratories (NYSE:ABT) from Medical Appliances & Equipment – Todays Top Gains - Twin County News
06/30/16 10:07 AMAbbott Laboratories (ABT) Pops 2.69% for June 29 - Equities.com
06/30/16 08:09 AMResearch Report Initiated on Select Medical Appliances and Equipment Equities -
06/30/16 06:00 AMHealthcare: Stock Selection Increasingly Important -
06/29/16 01:42 PMAbbott Laboratories : ABT-US: Dividend Analysis : July 15th, 2016 (record date) : By the numbers : June 29, 2016 -
06/29/16 10:10 AMAbbott Laboratories (NYSE:ABT): Taking a look at the Consensus Estimates from Analysts - Telanagana Press
06/29/16 10:10 AMHC Stocks Newsbeat: Abbott Laboratories (NYSE:ABT), Agilent Technologies Inc (NYSE:A) - share market updates (press release)
06/29/16 10:10 AMAnalyst Rating Update on Abbott Laboratories (ABT) - Trade Calls
06/29/16 10:10 AMAbout Abbott Labs' Acquisition Of St. Jude Medical - Seeking Alpha
06/28/16 07:27 PMWorth Watching Stocks to Track: Abbott Laboratories (NYSE:ABT), Vista Gold Corp.(NYSEMKT:VGZ) - NYSE Journal (press release)
06/28/16 02:15 PMShare Update and Earnings Review for Abbott Laboratories (NYSE:ABT) - Press Telegraph
06/28/16 07:02 AMShares in Decline this Year Abbott Laboratories (NYSE:ABT) - Press Telegraph
06/27/16 02:16 PMStrong Sell Calls Recommendations For Abbott Laboratories (NYSE:ABT) At 0 - Investor Newswire
06/27/16 02:16 PMSymantec Corporation (NASDAQ:SYMC) & Abbott Laboratories (NYSE:ABT) Worth Watching Stocks - Wall Street 24
06/27/16 02:16 PMHot Stocks Alert - Abbott Laboratories, (NYSE:ABT), Gastar Exploration, (NYSEMKT:GST) - Hot Stocks Point
06/27/16 02:15 PMETF’s with exposure to Abbott Laboratories : June 27, 2016 -
06/27/16 10:08 AMWhat’s the Verdict on Becton Dickinson’s Strategic Portfolio Review? -
06/27/16 07:02 AMEquity Research and Technical Review on Abbott Laboratories (NYSE:ABT) - Press Telegraph
06/27/16 07:02 AMShares of Abbott Laboratories (NYSE:ABT) Sees Large Inflow of Net Money Flow - Trade Calls
06/26/16 02:15 PMAbbott Laboratories (NYSE:ABT) Broker Price Targets For The Coming Week - Fiscal Standard
06/26/16 12:00 PMWhy You Shouldn’t Talk About Your Old Job in a New Role -
06/25/16 02:15 PMStock Performance Focus on: Abbott Laboratories (NYSE:ABT) - Press Telegraph
06/25/16 11:05 AMHow Did Roche’s Diagnostics Division Perform? -
06/24/16 07:28 PMIntraday Movers - Abbott Laboratories, (NYSE:ABT), MGM Resorts International, (NYSE:MGM) - Hot Stocks Point
06/24/16 10:12 AMThis Is What Makes Abbott Laboratories Great
06/24/16 09:38 AMAbbott Laboratories :ABT-US: Earnings Analysis: Q1, 2016 By the Numbers : June 24, 2016 -
06/24/16 07:17 AMAbbott Laboratories breached its 50 day moving average in a Bullish Manner : ABT-US : June 24, 2016 -
06/23/16 08:26 PMAbbott Laboratories (NYSE:ABT) & Emergent Biosolutions (NYSE:EBS) are Hot Healthcare Stocks - Wall Street 24
06/23/16 02:22 PMHC Stocks Broker Alerts: MannKind Corporation (NASDAQ:MNKD), Abbott Laboratories (NYSE:ABT) - share market updates (press release)
06/23/16 02:22 PMMost recent Analysts Rating report: Abbott Laboratories (NYSE:ABT) , CVS Health Corporation (NYSE:CVS) - Street Updates
06/23/16 02:22 PMThis Is What Makes Abbott Laboratories Great - Seeking Alpha
06/23/16 10:00 AMCovered Call reports for Apple, SolarCity, Skyworks Solutions, NVIDIA, and Abbott Laboratories include trade ideas that offer returns of 20% or more!
06/23/16 10:00 AMMarket Update (NYSE:ABT): Abbott Hosts Conference Call for Second-Quarter Earnings
06/23/16 10:00 AMAbbott Laboratories (ABT) is Upgraded by Edward Jones to Buy
06/22/16 10:34 PMAbbott Laboratories : ABT-US: Dividend Analysis : July 15th, 2016 : By the numbers : June 23, 2016 -
06/22/16 07:26 PMAbbott: The Best Laid Plans...Or Not? - Seeking Alpha
06/22/16 07:26 PMAbbott Laboratories (ABT) Marked As A Barbarian At The Gate - TheStreet.com
06/22/16 06:52 PMCramer: Without business from Apple, it's treading water -
06/22/16 02:15 PMTop Gainers of the Day: Abbott Laboratories (NYSE:ABT) from Medical Appliances & Equipment - Twin County News
06/22/16 08:00 AMAbbott Hosts Conference Call for Second-Quarter Earnings - [PR Newswire] - ABBOTT PARK, Ill., June 22, 2016 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its second-quarter 2016 financial results on Wednesday, July 20, 2016, before the market opens. The announcement will ...
06/22/16 07:02 AMHC Stocks Overview: Boston Scientific Corporation (NYSE:BSX), Abbott Laboratories (NYSE:ABT) - share market updates (press release)
06/22/16 07:02 AMAnalysts Update on Stocks: Abbott Laboratories (NYSE:ABT) , PhotoMedex, Inc. (NASDAQ:PHMD) - Street Updates
06/21/16 07:02 AMTake a look at Analysts Tips: Abbott Laboratories (NYSE:ABT) , Fate Therapeutics, Inc. (NASDAQ:FATE) - Street Updates
06/20/16 02:15 PMMarvell Technology Group (NASDAQ:MRVL) & Abbott Laboratories (NYSE:ABT) Investor's Watch List - Wall Street 24
06/20/16 08:48 AMHC Stocks Review: Johnson & Johnson (NYSE:JNJ), Abbott Laboratories (NYSE:ABT) - share market updates (press release)
06/20/16 08:47 AMStrong Buy Calls Count For Abbott Laboratories (NYSE:ABT) At 9 - Investor Newswire
06/18/16 09:00 PMOpinions Differ on Abbott Deal to Acquire St. Jude's Medical -
About Abbott Laboratories

Abbott Laboratories logoAbbott Laboratories (Abbott) is engaged in the discovery, development, manufacture and sale of a line of healthcare products. The Company operates in four business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. The Established Pharmaceutical Products segment includes the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment includes the sales of a line of adult and pediatric nutritional products. The Nutritional Products includes the sales of diagnostic systems and tests for blood banks, commercial laboratories and alternate-care testing sites. The Vascular Products includes the sales of coronary, endovascular, structural heart, vessel closure and other medical device products. Its Established Pharmaceutical Products segment's therapeutic area portfolio of products includes gastroenterology products, women's health products, and respiratory drugs and vaccines.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NYSE
  • Symbol: ABT
  • CUSIP: 00282410
Key Metrics:
  • Previous Close: $39.31
  • 50 Day Moving Average: $38.30
  • 200 Day Moving Average: $40.21
  • P/E Ratio: 24.45
  • P/E Growth: 1.90
  • Market Cap: $58.34B
  • Current Quarter EPS Consensus Estimate: $2.20 EPS
Additional Links:
Abbott Laboratories (NYSE:ABT) Chart for Friday, July, 1, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha